| scholarly article | Q13442814 |
| P50 | author | Thirumagal Kanagasabai | Q57011677 |
| P2093 | author name string | David J Kelvin | |
| Yuan Fang | |||
| Alyson A Kelvin | |||
| David Banner | |||
| Stephen S H Huang | |||
| Derek C K Ng | |||
| P2860 | cites work | Pandemic potential of a strain of influenza A (H1N1): early findings | Q24286924 |
| Comparative analysis of evolutionary mechanisms of the hemagglutinin and three internal protein genes of influenza B virus: multiple cocirculating lineages and frequent reassortment of the NP, M, and NS genes | Q24517349 | ||
| The evolution of human influenza viruses | Q24522380 | ||
| Recommended viruses for influenza vaccines for use in the 2010-2011 northern hemisphere influenza season | Q83152060 | ||
| Comparison of the mutation rates of human influenza A and B viruses | Q24542982 | ||
| Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls | Q24556678 | ||
| Efficacy of 2'-deoxy-2'-fluororibosides against influenza A and B viruses in ferrets | Q24611087 | ||
| RNA virus genomics: a world of possibilities | Q27489430 | ||
| Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009 | Q28260987 | ||
| Genetic diversity of influenza B virus: the frequent reassortment and cocirculation of the genetically distinct reassortant viruses in a community | Q28272541 | ||
| Influenza B virus evolution: co-circulating lineages and comparison of evolutionary pattern with those of influenza A and C viruses | Q28294302 | ||
| Influenza: old and new threats | Q28296381 | ||
| Oseltamivir-resistant pandemic A/H1N1 virus is as virulent as its wild-type counterpart in mice and ferrets | Q28474889 | ||
| Mortality associated with influenza and respiratory syncytial virus in the United States | Q29615578 | ||
| In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses | Q29619174 | ||
| Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice | Q29619193 | ||
| Avian influenza and human health. | Q30330442 | ||
| Pandemic (avian) influenza. | Q30361293 | ||
| Emerging influenza virus: a global threat. | Q30374880 | ||
| Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets. | Q30378627 | ||
| Seasonal, avian, and novel H1N1 influenza: prevention and treatment modalities. | Q30382632 | ||
| Risk factors and outcomes among children admitted to hospital with pandemic H1N1 influenza. | Q30382712 | ||
| Pandemic (H1N1) 2009 influenza. | Q30384133 | ||
| Comparison of the pathology caused by H1N1, H5N1, and H3N2 influenza viruses. | Q30387087 | ||
| Modeling host responses in ferrets during A/California/07/2009 influenza infection | Q30387263 | ||
| Differing symptom patterns in early pandemic vs seasonal influenza infections. | Q30389593 | ||
| Molecular characterization of in vivo adjuvant activity in ferrets vaccinated against influenza virus | Q30390170 | ||
| The 2009 A (H1N1) influenza virus pandemic: A review | Q30390380 | ||
| In vivo ribavirin activity against severe pandemic H1N1 Influenza A/Mexico/4108/2009. | Q30393080 | ||
| NS-based live attenuated H1N1 pandemic vaccines protect mice and ferrets | Q30394706 | ||
| Pathogenesis of avian influenza A (H5N1) viruses in ferrets | Q34999473 | ||
| Avian influenza virus: of virus and bird ecology | Q37617659 | ||
| Differences in clinical features between influenza A H1N1, A H3N2, and B in adult patients | Q40558910 | ||
| Assessment of signs of influenza illness in the ferret model | Q40776218 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pandemic | Q12184 |
| P304 | page(s) | e27512 | |
| P577 | publication date | 2011-01-01 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Comparative analyses of pandemic H1N1 and seasonal H1N1, H3N2, and influenza B infections depict distinct clinical pictures in ferrets | |
| P478 | volume | 6 |
| Q33898222 | Age dependent differences in the kinetics of γδ T cells after influenza vaccination |
| Q90484018 | Age-Related Pathology Associated with H1N1 A/California/07/2009 Influenza Virus Infection |
| Q27024582 | Animal models for influenza virus pathogenesis, transmission, and immunology |
| Q34809686 | Animal models for influenza viruses: implications for universal vaccine development |
| Q30422094 | Characterization of the 2009 pandemic A/Beijing/501/2009 H1N1 influenza strain in human airway epithelial cells and ferrets |
| Q33441325 | Clinical differences of influenza subspecies among hospitalized children |
| Q28553195 | Competitive Fitness of Influenza B Viruses Possessing E119A and H274Y Neuraminidase Inhibitor Resistance-Associated Substitutions in Ferrets |
| Q30224586 | Concurrent 2009 pandemic influenza A (H1N1) virus infection in ferrets and in a community in Pennsylvania. |
| Q40090039 | Conformational modulation of influenza virus hemagglutinin: characterization and in vivo efficacy of monomeric form |
| Q30422167 | Differential pathological and immune responses in newly weaned ferrets are associated with a mild clinical outcome of pandemic 2009 H1N1 infection |
| Q38029020 | Domestic animal models for biomedical research |
| Q28393999 | Environmental Conditions Affect Exhalation of H3N2 Seasonal and Variant Influenza Viruses and Respiratory Droplet Transmission in Ferrets |
| Q26823772 | Ferret models of viral pathogenesis |
| Q30357273 | H1N1, but not H3N2, influenza A virus infection protects ferrets from H5N1 encephalitis. |
| Q90381195 | Historical H1N1 Influenza Virus Imprinting Increases Vaccine Protection by Influencing the Activity and Sustained Production of Antibodies Elicited at Vaccination in Ferrets |
| Q39431643 | Immunity toward H1N1 influenza hemagglutinin of historical and contemporary strains suggests protection and vaccine failure |
| Q30396738 | Impact of influenza in the post-pandemic phase: Clinical features in hospitalized patients with influenza A (H1N1) pdm09 and H3N2 viruses, during 2013 in Santa Fe, Argentina |
| Q30365379 | Impaired heterologous immunity in aged ferrets during sequential influenza A H1N1 infection. |
| Q28395364 | Influenza H1N1pdm-specific maternal antibodies offer limited protection against wild-type virus replication and influence influenza vaccination in ferrets |
| Q36137235 | Influenza Transmission in the Mother-Infant Dyad Leads to Severe Disease, Mammary Gland Infection, and Pathogenesis by Regulating Host Responses |
| Q27321447 | Influenza vaccination accelerates recovery of ferrets from lymphopenia |
| Q30429787 | Intranasal vaccination with H5, H7 and H9 hemagglutinins co-localized in a virus-like particle protects ferrets from multiple avian influenza viruses |
| Q30361318 | Lack of group X secreted phospholipase A₂ increases survival following pandemic H1N1 influenza infection. |
| Q36242184 | Mouse adaptation of influenza B virus increases replication in the upper respiratory tract and results in droplet transmissibility in ferrets |
| Q30356527 | Pandemic H1N1 influenza A directly induces a robust and acute inflammatory gene signature in primary human bronchial epithelial cells downstream of membrane fusion. |
| Q42208634 | Pathogenic influenza B virus in the ferret model establishes lower respiratory tract infection |
| Q40094068 | Pathogenicity and peramivir efficacy in immunocompromised murine models of influenza B virus infection |
| Q42283189 | Patients hospitalized with laboratory-confirmed influenza during the 2010-2011 influenza season: exploring disease severity by virus type and subtype |
| Q27336918 | Peripheral Leukocyte Migration in Ferrets in Response to Infection with Seasonal Influenza Virus |
| Q92690560 | Quantitative efficacy paradigms of the influenza clinical drug candidate EIDD-2801 in the ferret model |
| Q60047813 | Rationale for vaccination with trivalent or quadrivalent live attenuated influenza vaccines: Protective vaccine efficacy in the ferret model |
| Q36037316 | Recombinant H7 hemagglutinin forms subviral particles that protect mice and ferrets from challenge with H7N9 influenza virus |
| Q30372696 | Recombinant virus-like particles elicit protective immunity against avian influenza A(H7N9) virus infection in ferrets. |
| Q38104075 | Selected emerging diseases in ferrets |
| Q30424696 | Sequencing, annotation, and characterization of the influenza ferret infectome |
| Q39454744 | Severe influenza in children: incidence and risk factors |
| Q93160589 | Severity and outcomes of influenza-related pneumonia in type A and B strains in China, 2013-2019 |
| Q30366406 | Severity of clinical disease and pathology in ferrets experimentally infected with influenza viruses is influenced by inoculum volume. |
| Q47132665 | Single-walled carbon nanotubes modulate pulmonary immune responses and increase pandemic influenza a virus titers in mice |
| Q92591044 | The tree shrew is a promising model for the study of influenza B virus infection |
| Q27000668 | Using the Ferret as an Animal Model for Investigating Influenza Antiviral Effectiveness |
Search more.